Astrocyte Pharmaceuticals Inc.
Manufacturing · Connecticut, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
93 Shennecossett Rd, Groton, Connecticut...Phone Number
(617) 444-8765Website
www.astrocytepharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Astrocyte Pharmaceuticals Inc.
Astrocyte Pharmaceuticals Inc. is a privately held drug development company dedicated to accelerating the recovery and well-being of brain injury patients. The company is committed to proving the neuroprotective benefits of enhancing astrocyte function, and advancing breakthrough therapeutic agents for treating brain injury resulting from stroke, TBI, concussion, and neurodegenerative disorders such as Alzheimer's disease. Established in 2014, Astrocyte Pharmaceuticals Inc. is headquartered in Connecticut, United States.Explore more
Astrocyte Pharmaceuticals Inc. Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Astrocyte Pharmaceuticals Inc. your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Astrocyte Pharmaceuticals Inc. had a recent Job posting/layoffs
Earning: See what the market has to say on Astrocyte Pharmaceuticals Inc. recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Astrocyte Pharmaceuticals Inc., which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Astrocyte Pharmaceuticals Inc. launches new products
Check out if Astrocyte Pharmaceuticals Inc. is spiking on competitors!
Funding: Get notified immidiatlly once Astrocyte Pharmaceuticals Inc. has new funding data
Congratulate Masked Content for being promoted to Masked Content at Astrocyte Pharmaceuticals Inc.
Check if Astrocyte Pharmaceuticals Inc. has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Astrocyte Pharmaceuticals Inc. as Masked Content
Find 2 more new buyers
Compare Similar Companies to Astrocyte Pharmaceuticals Inc.
Compare insights from companies similar to Astrocyte Pharmaceuticals Inc., focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Astrocyte Pharmaceuticals...
<$5M
1-10
Private
$12M
2014
EM
Elizabeth MannaVice President, Clinical Development Operations
Company Profile Activity
Activity Insights
Astrocyte Pharmaceuticals Inc. is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Astrocyte Pharmaceuticals Inc. is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Astrocyte Pharmaceuticals Inc..
Astrocyte Pharmaceuticals Inc. financials insights
Gather financial insights about Astrocyte Pharmaceuticals Inc., including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Series A
$6M
2023
Other Financing Round
$6M
Astrocyte Pharmaceuticals Inc. Tech Stack
A closer look at the technologies used by Astrocyte Pharmaceuticals Inc.
Astrocyte Pharmaceuticals Inc. News & Media
Astrocyte Pharmaceuticals Announces Milestones in the Fight Against Concussions: Launch of Phase 2 Clinical Trial and New $3M NIH Grant
Astrocyte Pharmaceuticals Announces Milestones in the Fight Against Concussions: Launch of Phase 2 Clinical Trial and New $3M NIH GrantAlzheimer's Drug Discovery Foundation Joins Astrocyte Pharmaceuticals’ $6M Pre-Series B Financing Round to Expand Development of Cerebroprotectant AST-004
GROTON, Conn.--(BUSINESS WIRE)--Astrocyte Pharmaceuticals Inc., a clinical-stage drug discovery and development company advancing novel cerebroprotective therapeutics for patients with brain injuries, announced an oversubscribed pre-Series B Bridge financing round of over $6M that was led by Dreavent Capital, and joined by the Alzheimer's Drug Discovery Foundation, and other investors. The funding will accelerate the clinical development of AST-004, a highly promising therapeutic candidate aimeAstrocyte Pharmaceuticals Announces Theodore Liston, Ph.D., Vice President of Research, as Recipient of the 2022 Innovation and Progress Award from the Journal Stroke
GROTON, Conn.--(BUSINESS WIRE)--Astrocyte Pharmaceuticals Inc., a private drug discovery and development company advancing novel cerebroprotective therapeutics for patients with brain injuries, today announced that Theodore Liston, Ph.D., Vice President of Research at Astrocyte, received the 2022 Progress and Innovation Award from the journal Stroke for authoring one of the journal’s top three publications in 2022. The Innovation and Progress Award recognizes research that demonstrates “a new aAstrocyte Announces Initiation of an Extended Infusion Phase 1B Study of AST-004 for Stroke and Traumatic Brain Injuries
GROTON, Conn.--(BUSINESS WIRE)--Astrocyte Pharmaceuticals Inc., a drug discovery and development company advancing novel cerebroprotective therapeutics for patients with brain injuries, is pleased to announce the initiation of a Phase 1B study of its lead candidate, AST-004, as an extended infusion in healthy volunteers. This adaptive-design clinical study will be conducted over the next four to six months at the QPS clinical research site in Groningen, Netherlands. AST-004 is a small molecule
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Astrocyte Pharmaceuticals Inc.
Sign Up For FreeTo access detailed company insights
Astrocyte Pharmaceuticals Inc. is a privately held drug development company dedicated to accelerating the recovery and well-being of brain injury patients. The company is committed to proving the neuroprotective benefits of enhancing astrocyte function, and advancing breakthrough therapeutic agents for treating brain injury resulting from stroke, T... Read More
